Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Niels Vandewalle actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Actief
Onderzoeksoutput
-
Activated cDCs by aCD40 therapy induce anti-tumor effects in Multiple Myeloma
Verheye, E., Kancheva, D., Satilmis, H., Vandewalle, N., Fan, R., Bardet, P., Clappaert, E., Vanderkerken, K., De Veirman, K. & Laoui, D., 2023, (Unpublished).Onderzoeksoutput: Poster
-
Elevated LAG-3 expression in plasma cells and lymphoid subpopulations at distinct stages of Multiple Myeloma disease progression
Satilmis, H., Vandewalle, N., Verheye, E., Fan, R., De Bruyne, E., Menu, E., Devoogdt, N., Vanderkerken, K., Breckpot, K. & De Veirman, K., 29 sep 2023, (Unpublished).Onderzoeksoutput: Poster
-
Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
Satilmis, H., Verheye, E., Vlummens, P., Oudaert, I., Vandewalle, N., Fan, R., Knight, J., De Beule, N., Ates, G., Massie, A., Moreaux, J., Maes, A., De Bruyne, E., Vanderkerken, K., Menu, E., Sloan, E. & De Veirman, K., jan 2023, In: Journal of pathology. 259, 1, blz. 69–80 12 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand2 Citaten (Scopus)9 Downloads (Pure) -
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Fan, R., Satilmis, H., Vandewalle, N., Verheye, E., Vlummens, P., Maes, A., Muylaert, C., De Bruyne, E., Menu, E., Evans, H., Chantry, A., De Beule, N., Hose, D., Töngren, M., Eriksson, H., Vanderkerken, K., Maes, K., Breckpot, K. & De Veirman, K., 17 jan 2023, In: Journal for ImmunoTherapy Of Cancer. 11, 1, A8.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Citaat (Scopus)6 Downloads (Pure) -
The multifaceted anti-cancer effects of the immunomodulator Tasquinimod in Multiple Myeloma
Fan, R., Verheye, E., Satilmis, H., Vandewalle, N., De Bruyne, E., Menu, E., De Beule, N., Hose, D., Vanderkerken, K., Breckpot, K., Maes, K. & De Veirman, K., 4 feb 2022.Onderzoeksoutput: Poster
Activiteiten
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
3 feb 2023Activiteit: Talk or presentation at a conference
-
Mapping the immune heterogeneity within the myeloma microenvironment using single-cell transcriptomics
Emma Verheye (Speaker), Rong Fan (Contributor), Hatice Satilmis (Contributor), Niels Vandewalle (Contributor), Pauline Bardet (Contributor), Emile Clappaert (Contributor), Daliya Kancheva (Contributor), Elke De Bruyne (Contributor), Karin Vanderkerken (Contributor), Kim De Veirman (Contributor) & Damya Laoui (Contributor)
3 feb 2023Activiteit: Talk or presentation at a conference
-
LSM-PhD Day 2023
Niels Vandewalle (Organiser), Heleen Hanssens (Organiser), Hamide Yildirim (Organiser), Arne Wyns (Organiser), Lien Ann Van Hemelrijck (Organiser), Catharina Muylaert (Organiser), Charlotte Janssens (Organiser), Michiel De Coster (Organiser) & Laura De Pauw (Organiser)
28 mrt 2023Activiteit: Participation in conference
-
Charity Quiz PhD United
Ellis Michiels (Organiser), Margo Willems (Organiser) & Niels Vandewalle (Organiser)
14 dec 2022Activiteit: Participating in or organizing a school event
-
LSM-PhD day 2022
Niels Vandewalle (Organiser) & Margo Willems (Organiser)
29 mrt 2022Activiteit: Participation in workshop, seminar
Scriptie
-
Targeting AXL, by small molecule inhibitors and Nanobody-based approaches, to eliminate cancer cells and improve chemotherapeutic responses in Acute Myeloid Leukemia
Auteur: De Veirman, K., Devoogdt, N., Breckpot, K. & Vandewalle, N., 18 jun 2020Scriptie/Masterproef: Master's Thesis